Search research articles
Contact Us
Filters
Showing results (51-60 of 119) with videos related to
Page
of 12
Sort By:
BMJ Open
|
April 14, 2021
Risks and benefits of antioxidant dietary supplement use during cancer treatment: protocol for a scoping review
L Susan Wieland, Ilana Moffet, Sydney Shade, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
September 20, 2023
Impact of pegaspargase dose capping on incidence of pegaspargase-related adverse events in adults
Emily Tiao, Ciera L Bernhardi, James A Trovato, et al.
Frontiers in Cardiovascular Medicine
|
June 26, 2023
Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population
Stacey Doran, Manu Mysore, Seyed Ebrahim Kassaian, et al.
Leukemia & Lymphoma
|
August 8, 2022
Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and <i>IDH1</i> R132C mutation
Hanan Alkhaldi, Danielle Sewell, Yi Ning, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 2026
Pharmacokinetics of venetoclax in a patient after whipple pancreaticoduodenectomy
Tien V Le, Allison Dunn, Julianne L Holleran, et al.
Frontiers in Oncology
|
May 1, 2024
Dual targeting of glutamine and serine metabolism in acute myeloid leukemia
Kanwal M Hameed, Dominique R Bollino, Amol C Shetty, et al.
BJU International
|
December 24, 2010
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity
Ashley E Ross, Ashkan Emadi, Luigi Marchionni, et al.
Cancer Causes & Control : CCC
|
October 9, 2023
Community-engaged basic science in an NCI-designated comprehensive cancer center: antioxidants and chemotherapeutic efficacy
Dominique Bollino, Nathaniel Woodard, Kayla M Tighe, et al.
Nutrition and Cancer
|
July 30, 2024
Effects of Antioxidant Dietary Supplement Use upon Response to Cancer Treatment: A Scoping Review of Available Evidence
L Susan Wieland, Sydney Shade, Ilana Moffet, et al.
BMC Structural Biology
|
January 30, 2016
A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone
Lakshmi Swarna Mukhi Pidugu, J C Emmanuel Mbimba, Muqeet Ahmad, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 119) with videos related to
Sort By:
Page
of 12
BMJ Open
|
April 14, 2021
Risks and benefits of antioxidant dietary supplement use during cancer treatment: protocol for a scoping review
L Susan Wieland, Ilana Moffet, Sydney Shade, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
September 20, 2023
Impact of pegaspargase dose capping on incidence of pegaspargase-related adverse events in adults
Emily Tiao, Ciera L Bernhardi, James A Trovato, et al.
Frontiers in Cardiovascular Medicine
|
June 26, 2023
Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population
Stacey Doran, Manu Mysore, Seyed Ebrahim Kassaian, et al.
Leukemia & Lymphoma
|
August 8, 2022
Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and <i>IDH1</i> R132C mutation
Hanan Alkhaldi, Danielle Sewell, Yi Ning, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 2026
Pharmacokinetics of venetoclax in a patient after whipple pancreaticoduodenectomy
Tien V Le, Allison Dunn, Julianne L Holleran, et al.
Frontiers in Oncology
|
May 1, 2024
Dual targeting of glutamine and serine metabolism in acute myeloid leukemia
Kanwal M Hameed, Dominique R Bollino, Amol C Shetty, et al.
BJU International
|
December 24, 2010
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity
Ashley E Ross, Ashkan Emadi, Luigi Marchionni, et al.
Cancer Causes & Control : CCC
|
October 9, 2023
Community-engaged basic science in an NCI-designated comprehensive cancer center: antioxidants and chemotherapeutic efficacy
Dominique Bollino, Nathaniel Woodard, Kayla M Tighe, et al.
Nutrition and Cancer
|
July 30, 2024
Effects of Antioxidant Dietary Supplement Use upon Response to Cancer Treatment: A Scoping Review of Available Evidence
L Susan Wieland, Sydney Shade, Ilana Moffet, et al.
BMC Structural Biology
|
January 30, 2016
A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone
Lakshmi Swarna Mukhi Pidugu, J C Emmanuel Mbimba, Muqeet Ahmad, et al.
Page
of 12